Review Article
2021 updates in postoperative radiotherapy section of Chinese Society of Clinical Oncology Breast Cancer guideline
Translational Breast Cancer Research
2021;
2:
22
(31 July 2021)
Review Article
St. Gallen 2021 Chinese expert perspective of optimal regional management
Translational Breast Cancer Research
2021;
2:
21
(31 July 2021)
Review Article
A review of endocrine therapy in early estrogen receptor-positive breast cancer by St. Gallen Breast Cancer Conference 2021
Translational Breast Cancer Research
2021;
2:
20
(31 July 2021)
Review Article
Optimizing HER2-positive breast cancer therapy through neoadjuvant platforms: controversies and concepts
Translational Breast Cancer Research
2021;
2:
19
(31 July 2021)
Review Article
Introduction to the key contents of the Chinese Society of Breast Surgery Practice Guideline 2021
Translational Breast Cancer Research
2021;
2:
18
(31 July 2021)
Review Article
Expert review on systemic treatment in the St. Gallen International Breast Cancer Conference 2021
Translational Breast Cancer Research
2021;
2:
17
(31 July 2021)
Case Report
A case report of primary squamous cell carcinoma of the breast
Translational Breast Cancer Research
2021;
2:
16
(30 April 2021)
Case Report
T-DM1 for advanced breast cancer after multi-anti-HER2-target therapy: a case report
Translational Breast Cancer Research
2021;
2:
15
(30 April 2021)
Case Report
Benefit with re-challenge of immune checkpoint inhibitors in patient with metastatic triple-negative breast cancer: a case report
Translational Breast Cancer Research
2021;
2:
14
(30 April 2021)
Review Article
Cyclin-dependent kinase 4 and 6 inhibitors at the crossroads: the combinational therapeutic strategies in breast cancer—a narrative review
Translational Breast Cancer Research
2021;
2:
13
(30 April 2021)
Review Article
Potential biomarkers of resistance to CDK4/6 inhibitors: a narrative review of preclinical and clinical studies
Translational Breast Cancer Research
2021;
2:
12
(30 April 2021)
Original Article
The role of FOXP3 of interstitial tissue in the pathogenesis of breast cancer
Translational Breast Cancer Research
2021;
2:
11
(30 April 2021)
Editorial
How bone metastases can influence the management of breast cancer
Translational Breast Cancer Research
2021;
2:
10
(30 April 2021)
Editorial
Implementing clinical practice guidelines for breast cancer management: searching for homogeneity in real-life heterogeneity
Translational Breast Cancer Research
2021;
2:
9
(30 April 2021)
Case Report
Aggressive breast fibromatosis with axillary accessory breast mastitis mimicking carcinoma: a case report
Translational Breast Cancer Research
2021;
2:
8
(31 January 2021)
Review Article
Bone metabolism and the development of denosumab: a narrative review
Translational Breast Cancer Research
2021;
2:
7
(31 January 2021)
Review Article
The evolution and advances of biomarker use in clinical trials for breast cancer treatment—a narrative review
Translational Breast Cancer Research
2021;
2:
6
(31 January 2021)
Review Article
Reprogramming of fatty acid metabolism in breast cancer: a narrative review
Translational Breast Cancer Research
2021;
2:
5
(31 January 2021)
Original Article
Occurrence and distribution of bone metastases in 984 metastatic breast cancer patients
Translational Breast Cancer Research
2021;
2:
4
(31 January 2021)
Original Article
Prognosis prediction model for patients with breast cancer with bone metastasis: based on a population database
Translational Breast Cancer Research
2021;
2:
3
(31 January 2021)
Guideline
Chinese expert consensus statement on the clinical diagnosis and treatment of breast cancer bone metastasis and bone related disease
Translational Breast Cancer Research
2021;
2:
2
(31 January 2021)
Editorial
Expanding therapeutic frontiers in metastatic HER2-positive breast cancer
Translational Breast Cancer Research
2021;
2:
1
(31 January 2021)
Original Article
Markers of steroid receptor, kinase signalling pathways and Ki-67 expression in relation to tamoxifen sensitivity and resistance
Translational Breast Cancer Research
2020;
1:
29
(31 October 2020)
Original Article
Multidisciplinary treatment of breast cancer under COVID-19 pandemic
Translational Breast Cancer Research
2020;
1:
28
(31 October 2020)
Guideline
Guidelines of Chinese Society of Clinical Oncology (CSCO) on Diagnosis and Treatment of Breast Cancer (2020 version)
Translational Breast Cancer Research
2020;
1:
27
(31 October 2020)